Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 April 2020 | Story Baptiste Becret | Photo Supplied
Baptiste Becret.

Since the approval of the University of the Free State (UFS) internationalisation strategy for 2018-2022, the UFS community and staff members of the Office for International Affairs (OIA) have been working hard to try and realise the goals stated in the strategy. The policy states “the university's’ commitment to developing curricula that are locally relevant, globally competitive and connect to multiple knowledge paradigms”. Furthermore, “We expect that the new internationalisation strategy will advance the international positioning of the university, and synergise the existing rich international activities into intentional, comprehensive internationalisation processes”.

In an effort to realise the said expectations through the university’s inbound mobility programme, the Department of Afrikaans and Dutch, German and French in the Faculty of the Humanities has hired Baptiste Becret, an exchange student from French partner university, Science PO Bordeaux, as French tutor for the first semester of 2020. This collaboration by the two departments endeavours to achieve the university’s vision of developing its students’ international and intercultural competencies through internationalisation at home. Equally, this initiative speaks to a critical aspect of internationalisation, the “purposeful integration of international and intercultural dimensions into the formal curriculum for the UFS students within the domestic learning environment”.

Being the only Frenchman on campus

“I was the only Frenchman on campus and at the university, which I rather enjoyed. I learned at the beginning of this year, in January, that I could share my culture and language by helping students participating in the first- and second-year French courses at the university. For my part, I was attached to the Faculty of the Humanities. I've already had experience as a tutor in France, so I wasn't very stressed at the idea of being in front of a class. I enjoyed trying to teach my mother tongue. My contact with the French teacher was good. He gave me a lot of freedom to do the activities I wanted to do.

I didn't think that passing on my knowledge to the first-year class would be so difficult. Indeed, for some of them, they have never spoken a word of French. But the atmosphere improved from class to class after a shy start. I hope I was able to help them as best I could. In any case, I was very happy to teach them and to assist them in their various difficulties with the language. For the second-year class, the atmosphere was a little different. The class was smaller, the students already knew each other well, and they were pretty close. Additionally, their language level was already good. 

All this to say that being a French tutor was a great experience. It was enriching for both parties (students and me). Of course, I tried to do the best I could, and I took advantage of the free time my schedule gave me to share a little bit of my home country. So, I advise future international students – if they feel comfortable with that – to give it a try. It's only two hours a week with a little bit of extra money. Finally, I would like to thank the International Office for informing me of this opportunity, the people involved in the programme, including my coordinator, the French teacher, and especially the students who have been super cool to me.” 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept